CLINICAL OUTCOMES AND MOLECULAR CHARACTERIZATION FROM a PHASE II STUDY OF COPANLISIB IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
Lenz, G., Hawkes, E., Verhoef, G., Haioun, C., Lim, S., Heo, D., Ardeshna, K., Chong, G., Christensen, J.H., Shi, V., Lippert, S., Hiemeyer, F., Piraino, P., Beckmann, G., Peña, C., Buvaylo, V., ChildVolume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2437_56
Date:
June, 2017
File:
PDF, 112 KB
english, 2017